Robert J Bitterman Phio Pharmaceuticals Corp. (PHIO) insider trading activity

PHIO Quotes by TradingView

Robert J Bitterman is Chairman, Pres & CEO of Phio Pharmaceuticals Corp.. Currently has a direct ownership of 27,149 shares of PHIO, which is worth approximately $65,700. The most recent transaction as insider was on Jun 10, 2025, when has been sold 2,000 shares (Common Stock, $0.0001 par value) at a price of $2.42 per share, resulting in proceeds of $4,840. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27.1K
52.25% 3M change
29.34% 12M change
Total Value Held $65,700

Robert J Bitterman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 10 2025
BUY
Open market or private purchase
$4,840 $2.42 p/Share
2,000 Added 6.86%
27,149 Common Stock, $0.0001 ...
Jun 09 2025
BUY
Open market or private purchase
$4,125 $2.75 p/Share
1,500 Added 5.63%
25,149 Common Stock, $0.0001 ...
May 22 2025
BUY
Open market or private purchase
$2,136 $1.78 p/Share
1,200 Added 4.83%
23,649 Common Stock, $0.0001 ...
May 21 2025
BUY
Open market or private purchase
$5,310 $1.77 p/Share
3,000 Added 11.79%
22,449 Common Stock, $0.0001 ...
Sep 11 2024
BUY
Grant, award, or other acquisition
-
15,500 Added 46.5%
17,832 Common Stock, $0.0001 ...
Jun 07 2024
BUY
Open market or private purchase
$740 $0.74 p/Share
1,000 Added 4.55%
20,990 Common Stock, $0.0001 ...
Jun 06 2024
BUY
Open market or private purchase
$750 $0.75 p/Share
1,000 Added 4.76%
19,990 Common Stock, $0.0001 ...
Feb 26 2024
BUY
Open market or private purchase
$2,275 $0.91 p/Share
2,500 Added 11.63%
18,990 Common Stock, $0.0001 ...
Feb 20 2024
SELL
Payment of exercise price or tax liability
$1,371 $0.76 p/Share
1,804 Reduced 9.86%
16,490 Common Stock, $0.0001 ...
Oct 01 2023
SELL
Payment of exercise price or tax liability
$1,384 $1.51 p/Share
917 Reduced 4.77%
18,294 Common Stock, $0.0001 ...
Jul 01 2023
BUY
Open market or private purchase
$2,840 $2.84 p/Share
1,000 Added 4.95%
19,211 Common Stock, $0.0001 ...
Jun 30 2023
BUY
Open market or private purchase
$2,880 $2.88 p/Share
1,000 Added 5.21%
18,211 Common Stock, $0.0001 ...
Feb 20 2023
BUY
Grant, award, or other acquisition
-
11,000 Added 38.99%
17,211 Common Stock, $0.0001 ...
Dec 14 2022
BUY
Open market or private purchase
$780 $0.39 p/Share
2,000 Added 2.61%
74,541 Common Stock, $0.0001 ...
Dec 07 2022
BUY
Open market or private purchase
$780 $0.39 p/Share
2,000 Added 2.68%
72,541 Common Stock, $0.0001 ...
Dec 05 2022
BUY
Open market or private purchase
$860 $0.43 p/Share
2,000 Added 2.76%
70,541 Common Stock, $0.0001 ...
Nov 29 2022
BUY
Open market or private purchase
$86 $0.4 p/Share
215 Added 0.31%
68,541 Common Stock, $0.0001 ...
Nov 25 2022
BUY
Open market or private purchase
$1,050 $0.42 p/Share
2,500 Added 3.53%
68,326 Common Stock, $0.0001 ...
Nov 16 2022
BUY
Open market or private purchase
$1,750 $1750.0 p/Share
1 Added 50.0%
1 Series D Preferred Sto...
Oct 01 2022
BUY
Grant, award, or other acquisition
-
40,000 Added 37.8%
65,826 Common Stock, $0.0001 ...
Feb 15 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 27.91%
25,826 Common Stock, $0.0001 ...
Mar 01 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 38.72%
15,826 Common Stock, $0.0001 ...
RJB

Robert J Bitterman

Chairman, Pres & CEO
Marlborough, MA

Track Institutional and Insider Activities on PHIO

Follow Phio Pharmaceuticals Corp. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PHIO shares.

Notify only if

Insider Trading

Get notified when an Phio Pharmaceuticals Corp. insider buys or sells PHIO shares.

Notify only if

News

Receive news related to Phio Pharmaceuticals Corp.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PHIO